NAVIDEA BIOPHARMACEUTICALS, INC. Annual Cost of Revenue in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Navidea Biopharmaceuticals, Inc. quarterly/annual Cost of Revenue history and growth rate from 2017 to 2022.
  • Navidea Biopharmaceuticals, Inc. Cost of Revenue for the quarter ending December 31, 2022 was $36.000.
  • Navidea Biopharmaceuticals, Inc. Cost of Revenue for the twelve months ending December 31, 2022 was $1.94K.
  • Navidea Biopharmaceuticals, Inc. annual Cost of Revenue for 2022 was $1.94K.
  • Navidea Biopharmaceuticals, Inc. annual Cost of Revenue for 2021 was $0.000, a 100% decline from 2020.
  • Navidea Biopharmaceuticals, Inc. annual Cost of Revenue for 2020 was $1.05K, a 84.3% decline from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $1.94K +$1.94K Jan 1, 2022 Dec 31, 2022 10-K 2023-03-27
2021 $0 -$1.05K -100% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $1.05K -$5.62K -84.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $6.67K -$90K -93.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-26
2018 $96.6K +$93K +2547% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-18
2017 $3.65K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.